Singapore's co-developed vaccine candidate is in 'good shape' for delivery in 2021
November 26, 2020 at 23:31 PM EST
Positive results were announced by Singapore's Covid vaccine candidate ARCT-021, developed by Arcturus Therapeutics together with Duke-NUS Medical School.